Gene · 5698
Papers4,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 4,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas. | J Clin Med | 2022 | 36555876 | PubTator, text mining | PubMed |
| Molecular Characterisation of Epstein-Barr Virus in Classical Hodgkin Lymphoma. | Int J Mol Sci | 2022 | 36555277 | PubTator, text mining | PubMed |
| Intersections of Ubiquitin-Proteosome System and Autophagy in Promoting Growth of Glioblastoma Multiforme: Challenges and Opportunities. | Cells | 2022 | 36552827 | PubTator, text mining | PubMed |
| Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective. | Biomedicines | 2022 | 36552035 | PubTator, text mining | PubMed |
| Identification of DDX60 as a Regulator of MHC-I Class Molecules in Colorectal Cancer. | Biomedicines | 2022 | 36551849 | PubTator, text mining | PubMed |
| Human leukocyte antigen super-locus: nexus of genomic supergenes, SNPs, indels, transcripts, and haplotypes. | Hum Genome Var | 2022 | 36543786 | PubTator, text mining | PubMed |
| Immune landscape-based machine-learning-assisted subclassification, prognosis, and immunotherapy prediction for glioblastoma. | Front Immunol | 2022 | 36532035 | PubTator, text mining | PubMed |
| Deciphering Driver of Nasopharyngeal Cancer Development. | Oncol Rev | 2022 | 36531162 | PubTator, text mining | PubMed |
| Uncovering the gene regulatory network of type 2 diabetes through multi-omic data integration. | J Transl Med | 2022 | 36527108 | PubTator, text mining | PubMed |
| Intranasal inoculation of IFN-λ resolves SARS-CoV-2 lung infection via the rapid reduction of viral burden and improvement of tissue damage. | Front Immunol | 2022 | 36524125 | PubTator, text mining | PubMed |
| Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch. | J Immunother Cancer | 2022 | 36521927 | PubTator, text mining | PubMed |
| Performance of Localized-Orbital Coupled-Cluster Approaches for the Conformational Energies of Longer n-Alkane Chains. | J Phys Chem A | 2022 | 36508714 | PubTator, text mining | PubMed |
| Gene expression profiling in nucleus pulposus of human ruptured lumbar disc herniation. | Front Pharmacol | 2022 | 36506585 | PubTator, text mining | PubMed |
| An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy. | Front Immunol | 2022 | 36505399 | PubTator, text mining | PubMed |
| Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder. | Cancers (Basel) | 2022 | 36497432 | PubTator, text mining | PubMed |
| A Signaling Crosstalk Links SNAIL to the 37/67 kDa Laminin-1 Receptor Ribosomal Protein SA and Regulates the Acquisition of a Cancer Stem Cell Molecular Signature in U87 Glioblastoma Neurospheres. | Cancers (Basel) | 2022 | 36497426 | PubTator, text mining | PubMed |
| The Association between Infectious Mononucleosis and Cancer: A Cohort Study of 24,190 Outpatients in Germany. | Cancers (Basel) | 2022 | 36497319 | PubTator, text mining | PubMed |
| Functional Implications of Epstein-Barr Virus Lytic Genes in Carcinogenesis. | Cancers (Basel) | 2022 | 36497262 | PubTator, text mining | PubMed |
| An Update on the Metabolic Landscape of Oncogenic Viruses. | Cancers (Basel) | 2022 | 36497226 | PubTator, text mining | PubMed |
| Identification and Validation of RELN Mutation as a Response Indicator for Immune Checkpoint Inhibitor Therapy in Melanoma and Non-Small Cell Lung Cancer. | Cells | 2022 | 36497098 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5698/papers?page=29